AIEAX
Price
$19.10
Change
+$0.49 (+2.63%)
Updated
Jun 11 closing price
Net Assets
578.74M
HFQRX
Price
$8.20
Change
+$0.19 (+2.37%)
Updated
Jun 11 closing price
Net Assets
7.63B
Interact to see
Advertisement

AIEAX vs HFQRX

Header iconAIEAX vs HFQRX Comparison
Open Charts AIEAX vs HFQRXBanner chart's image
AIEAX vs HFQRX Comparison Chart in %
View a ticker or compare two or three
VS
AIEAX vs. HFQRX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIEAX is a Hold and HFQRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.63B vs. AIEAX (579M). HFQRX pays higher dividends than AIEAX: HFQRX (6.34) vs AIEAX (2.56). AIEAX was incepted earlier than HFQRX: AIEAX (16 years) vs HFQRX (11 years). AIEAX (1.23) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. AIEAX (49.00). AIEAX has a lower initial minimum investment than HFQRX: AIEAX (2500) vs HFQRX (1000000). HFQRX annual gain was more profitable for investors over the last year : 23.80 vs. AIEAX (9.97). HFQRX return over 5 years is better than : 63.30 vs. AIEAX (7.98).
AIEAXHFQRXAIEAX / HFQRX
Total Expense Ratio1.230.69178%
Annual Report Gross Expense Ratio1.230.69178%
Fund Existence16 years11 years-
Gain YTD6.82310.92662%
Front Load6%N/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets579M7.63B8%
Annual Yield % from dividends2.566.3440%
Returns for 1 year9.9723.8042%
Returns for 3 years18.6164.5129%
Returns for 5 years7.9863.3013%
Returns for 10 years41.47124.4333%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DELL391.4521.62
+5.85%
Dell Technologies
IMVT32.881.70
+5.45%
Immunovant
KMPR24.780.06
+0.24%
Kemper Corp
GRCE2.30-0.01
-0.43%
Grace Therapeutics Inc
ORGO2.38-0.09
-3.64%
Organogenesis Holdings